Number of Vioxx lawsuits continues to grow

10/17/2005 | Los Angeles Times (tiered subscription model)

The number of lawsuits against Merck over its withdrawn painkiller Vioxx has increased substantially over the past two months, with the company now facing more than 6,500 suits. Lawyers say some of the new cases were triggered by Merck's loss in the first case to go to trial, but a company spokesman said the new filings "are not unexpected and do not change our strategy."

View Full Article in:

Los Angeles Times (tiered subscription model)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Financial Officer
B. E. Smith
Miramar, FL
Claims Director
PacificSource
Springfield, OR
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA